Trial site
Florida Cancer Specialists
- 10running trials
- 7closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer6 trials
- Lung cancer4 trials
- Pancreatic cancer2 trials
- Childhood cancers1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 311 trials
- Phase 25 trials
- Phase 1/21 trial
- Status
- Active, not recruiting8 trials
- Completed7 trials
- Recruiting2 trials
- Lead sponsor
- Pfizer7 trials
- Eli Lilly and Company2 trials
- Bristol-Myers Squibb1 trial
- Epizyme, Inc.1 trial
- Gilead Sciences1 trial
- and 5 more
Running trials
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Active, not recruiting
Active, not recruiting
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026